Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Genomic Vision S.A. buy metanicnor

Start price
€6.30
25.02.16 / 50%
Target price
€17.00
25.08.16
Performance (%)
-22.54%
End price
€4.88
25.08.16
Summary
This prediction ended on 25.08.16 with a price of €4.88. The prediction for Genomic Vision S.A. disappointed with a performance of -22.54%. metanicnor has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Genomic Vision S.A. - - - -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by metanicnor for this prediction

In the thread Genomic Vision S.A. diskutieren
Prediction Buy
Perf. (%) -22.54%
Target price 17.000
Change
Ends at 25.08.16

gv

entreprise de biotechnologie specialisee dans la conception & la vente de tests de genetique moleculaire grace au peignage moleculaire qui detecte des variations des genes

elle a deja un partenaire aux etats unis quest diagnostic, le partenariat vient juste d'etre prolonge de 3 ans "avec une hausse significative du taux de royalties sur les prochaines ventes de tests par peignage moleculaire" selon le communique officiel

2 nouveaux tests devraient etre commercialises en 2015 http://bfmbusiness.bfmtv.com/mediaplayer/video/genomic-vision-aux-etats-unis-une-nouvelle-etape-dans-son-partenariat-avec-quest-diagnostics-aaron-bensimon-34-0702-439873.html

thanks to MadameButterfly for the following link : Genomic Vision eyes a big 2015 for molecular combing technologyFebruary 4, 2015 | By Emily Wasserman
http://www.fiercediagnostics.com/story/genomic-vision-eyes-big-2015-molecular-combing-technology/2015-02-04?utm_medium=nl&utm_source=internal

2015 : Une année clé pour Genomic Vision http://www.lerevenu.com/le-revenu-tv/la-parole-aux-dirigeants-de-societes/une-annee-cle-pour-genomic-vision

pour info : Bryan Garnier vise 23 €, Kepler Cheuvreux vise 17,5 €, la Societe Generale a un objectif de cours de 19 € & investir 17 €


Prediction Buy
Perf. (%) -22.54%
Target price 17.000
Change
Ends at 25.08.16

(Laufzeit überschritten)

Stopped prediction by metanicnor for Genomic Vision S.A.

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.29
02.03.19
€0.80
04.11.21
216.67%
22.11.20

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.81
29.08.18
€2.20
28.02.19
-63.44%
28.02.19

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€2.86
28.02.18
€8.00
29.08.18
-72.68%
29.08.18

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€2.82
29.08.17
€8.00
28.02.18
1.77%
28.02.18

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€5.00
28.02.17
€8.75
28.08.17
-42.20%
28.08.17

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€4.77
26.08.16
€8.75
27.02.17
2.52%
27.02.17

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€11.90
24.08.15
€17.00
24.02.16
-46.55%
24.02.16

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€15.80
24.02.15
€17.00
24.08.15
-19.62%
24.08.15

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€14.60
17.02.15
€15.80
24.02.15
9.25%
24.02.15

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€12.63
03.02.15
€14.00
17.02.15
11.56%
17.02.15

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€13.21
04.08.14
€17.00
03.02.15
-6.15%
03.02.15